Advertisement

A Study of Circadian Variation of Platelet Serotonin Uptake and Serum Cortisol in Patients with Major Depression

  • Jeffrey L. Rausch
  • Nandkumar S. Shah
  • Earl A. Burch
  • Alexander G. Donald
  • Ethan V. Munson

Abstract

The blood platelet shares many characteristics in common with synaptosomes, and has been suggested as a model for central serotoninergic neuronal functioning (Murphy et al., 1970; Stahl, 1977). Serotonin (5HT) has been indirectly implicated in the pathophysiology of depression (van Praag and Korf, 1971) and, as such, the uptake of 5HT into the platelet assumes potential importance as a possible indicator of central 5HT uptake activity, as both platelets and synaptosomes share similar Michaelis constants (K m ) for 5HT uptake to the nearest order of magnitude (Stahl and Meltzer, 1978; Smith et al., 1978).

Keywords

Serum Cortisol Blood Platelet Circadian Variation Serotonin Uptake Endogenous Depression 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Abraham, G. E., 1973, Radioimmunoassay of plasma steroid hormones, in: Modern Method of Steroid Analysis (E. Heftman, ed.), pp. 451–470, Academic Press, New York.Google Scholar
  2. Briley, M. S., Langer, S. Z., Raisman, R., Sechter, D., and Zarifian, E., 1980, Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients, Science 209:303.PubMedCrossRefGoogle Scholar
  3. Carroll, B. J., Curtis, G. C., and Mendels, J., 1976, Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction, Arch. Gen. Psychiatry 33:1039.PubMedCrossRefGoogle Scholar
  4. Coppen, A., Swade, C., and Wood, K., 1978, Platelet 5-hydroxytryptamine accumulation in depressive illness, Clin. Chim. Acta. 87:165.PubMedCrossRefGoogle Scholar
  5. Dumbrille-Ross, A., and Wa Tang, S., 1981, Absence of high affinity [3H] imipramine binding in platelets and cerebral cortex of fawn-hooded rats, Eur. J. Pharmacol. 72:137.PubMedCrossRefGoogle Scholar
  6. Fuller, R. W., 1981, Serotonergic stimulation of pituitary-adrenocortical function in rats, Prog. Neuroendocrinol. 32:118.CrossRefGoogle Scholar
  7. Hallstrom, C. O., Rees, W. L., Pare, C. M., Trenchard, A., and Turner, P., 1976, Platelet uptake of 5-hydroxytryptamine and dopamine in depression, Postgrad. Med. J. 52(Suppl. 3):40.PubMedCrossRefGoogle Scholar
  8. Kelly, W. F., Checkley, S. A., and Bender, D. A., 1980, Cushing’s syndrome, tryptophan and depression, Br. J. Psychiatry 136:125.PubMedCrossRefGoogle Scholar
  9. Krieger, D. T., 1973, Neurotransmitter regulation of ACTH release, Mt. Sinai J. Med. N. Y. 40:302.Google Scholar
  10. Krieger, D. T., 1978, Endocrine processes and serotonin, in: Serotonin in Health and Disease: The Central Nervous System (W. E. Essman, ed.), Vol. III, pp. 51–67, Spectrum Publications, New York.Google Scholar
  11. Langer, S. Z., Moret, C., Raisman, R., Dubocovich, M. L., and Briley, M., 1980, High affinity [3H] imipramine binding in rat hypothalamus: Association with uptake of serotonin but not of norepinephrine, Science 210:1133.PubMedCrossRefGoogle Scholar
  12. Lingjaerde, O., 1976, Effect of doxepin on uptake and efflux of serotonin in human blood platelets in vitro, Psychopharmacologia 47:183.PubMedCrossRefGoogle Scholar
  13. Lingjaerde, O., 1979, Inhibitory effect of clomipramine and related drugs on serotonin uptake in platelets: More complicated than previously thought, Psychopharmacology 61:245.PubMedCrossRefGoogle Scholar
  14. Manlimos, F. S., and Abraham, G. E., 1975, Chromatographic purification of tritiated steroids: Prior to use in radioimmunoassay, Anal. Lett. 8:403.CrossRefGoogle Scholar
  15. Meltzer, H. Y., Arora, R., Baber, R., Busch, D., Kaskey, G., Nasr, S., Piyakalamala, S., and Tricou, B. J., 1980, Serotonin uptake in blood platelets of depressed patients, Society of Biological Psychiatry, 35th Annual Convention and Scientific Program, Boston.Google Scholar
  16. Murphy, D. L., Colburn, R. W., Davis, J. M., and Bunney, W. E., Jr., 1970, Imipramine and lithium effects on biogenic amine transport in depressed and manic-depressed patients, Am. J. Psychiatry 127:339.PubMedGoogle Scholar
  17. Murphy, D. L., Campbell, I. C., and Costa, J. L., 1978, The brain serotonergic system in affective disorders, Prog. Neuropsychopharmacol. 2:5.PubMedCrossRefGoogle Scholar
  18. Oxenkrug, G. H., 1979, The content and uptake of 5HT by blood platelets in depressive patients, J. Neural Transm. 45:285.PubMedCrossRefGoogle Scholar
  19. Oxenkrug, G. H., Prakhje, I., and Mikhalenke, I. N., 1978, Disturbed circadian rhythm of 5HT uptake by blood platelets in depressive psychosis, Act. Nerv. Super. 20:66.Google Scholar
  20. Paul, S. M., and Rehavi, M., 1981, Imipramine binding in man and depressive illness, Presented at the American Psychiatric Association annual meeting, New Orleans.Google Scholar
  21. Ross, S. B., Aperia, B., Beck-Friis, J., Jansa, S., Wetterberg, L., and Aberg, A., 1980, Inhibition of 5-hydroxytryptamine uptake in human platelets by antidepressant agents in vivo, Psycho-pharmacology 67:1.Google Scholar
  22. Sachar, E. J., Hellman, L., Roffwarg, H. P., Halpern, F. S., Fukushima, D. K., and Gallagher, T. F., 1973, Disrupted 24-hour patterns of Cortisol secretion in psychotic depression, Arch. Gen. Psychiatry 28:19.PubMedCrossRefGoogle Scholar
  23. Scapagnini, U., Moberg, G. P., Van Loon, G. R., De Groot, J., and Ganong, W. F., 1971, Relation of brain 5-hydroxytryptamine content to the diurnal variation plasma corticosterone in the rat, Neuroendocrinology 7:90.PubMedCrossRefGoogle Scholar
  24. Shah, N. S., Burch, E. A., Yates, J. D., May, D. A., Donald, A. G., Freed, J. E., and Pressley, L. C., 1980, Dopamine uptake by human blood platelets, Res. Commun. Psychol. Psychiatr. Behav. 5:25.Google Scholar
  25. Shaw, D. M., MacSweeney, D. A., Woolcock, N., and Bevan-Jones, A. B., 1971, Uptake and release of 14C-5-hydroxytryptamine by platelets in affective illness, J. Neurol. Neurosurg. Psychiatry 34:224.PubMedCrossRefGoogle Scholar
  26. Smith, L. T., Hanson, D. R., and Omenn, G. S., 1978, Comparisons of serotonin uptake by blood platelets and brain synaptosomes, Brain. Res. 146:400.PubMedCrossRefGoogle Scholar
  27. Stahl, S. M., 1977, The human platelet: A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders, Arch. Gen. Psychiatry 34:509.PubMedCrossRefGoogle Scholar
  28. Stahl, S. M., and Meltzer, H. Y., 1978, A kinetic and pharmacologic analysis of 5-hydroxytryptamine transport by human platelets and platelet storage granules: Comparison with central serotonergic neurons, J. Pharmacol. Exp. Ther. 205:118.PubMedGoogle Scholar
  29. Syvälahti, E., Eneroth, P., and Ross, S. B., 1979, Acute effects of zimelidine and alaproclate, two inhibitors of serotonin uptake, on neuroendocrine function, Psychiatry Res. 1:111.PubMedCrossRefGoogle Scholar
  30. Tuomisto, J., Tukiainen, E., and Ahlfors, V. G., 1979, Decreased uptake of 5-hydroxytryptamine in blood platelets from patients with endogenous depression, Psychopharmacology 65:141.PubMedCrossRefGoogle Scholar
  31. Tuomisto, J., Tukiainen, E., Voutilainen, R., and Tuomainen, P., 1980, Inhibition of 5-hydroxytryptamine and noradrenaline uptake in platelets and synaptosomes incubated in plasma from human subjects treated with amitriptyline or nortriptyline: Utilization of the principle for a bioassay method, Psychopharmacology 69:137.PubMedCrossRefGoogle Scholar
  32. van Praag, H. M., and Korf, J., 1971, Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: A biochemical classification, Psychopharmacologia 19:148.PubMedCrossRefGoogle Scholar
  33. Vizi, E. S., Hàrsing, L. G., Jr., and Zsilla, G., 1981, Evidence of the modulatory role of serotonin in acetylcholine release from striatal interneurons, Brain. Res. 212:89.PubMedCrossRefGoogle Scholar
  34. Wirz-Justice, A., and Pühringer, W., 1978, Seasonal incidence of an altered diurnal rhythm of platelet serotonin in unipolar depression, J. Neural Transm. 42:45.PubMedCrossRefGoogle Scholar
  35. Wyatt, R. J., Murphy, D. L., Belmaker, R., Cohen, S., Donnelly, C. H., and Pollin, W., 1973, Reduced monoamine oxidase activity in platelets: A possible genetic marker for vulnerability to schizophrenia, Science 179:916.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1984

Authors and Affiliations

  • Jeffrey L. Rausch
    • 1
    • 2
  • Nandkumar S. Shah
    • 3
  • Earl A. Burch
    • 4
  • Alexander G. Donald
    • 4
  • Ethan V. Munson
    • 2
  1. 1.Ensor Foundation Research LaboratoryWilliam S. Hall Psychiatric InstituteColumbiaUSA
  2. 2.Department of PsychiatryUniversity of California at San DiegoLa JollaUSA
  3. 3.Ensor Research FoundationUSA
  4. 4.William S. Hall Psychiatric Institute, and Department of Neuropsychiatry and Behavioral SciencesUniversity of South Carolina School of MedicineColumbiaUSA

Personalised recommendations